Skip to content
Subscriber Only

AbbVie Said to Fire Heart Sales Force as Generics Compete

AbbVie Inc., the drugmaker split off from Abbott Laboratories this year, will fire its sales force for heart drugs as the medicines lose patent protection and face generic competition, according to a person familiar with the matter.

The firings total in the mid-hundreds and are a mix of AbbVie employees and contract workers, said the person, who asked not to be identified because they weren’t authorized to speak about the issue.